Mitchell E Taub Selected Research

Mitchell E Taub Research Topics

5	Breast Neoplasms (Breast Cancer) 12/2020 - 05/2012
2	Type 2 Diabetes Mellitus (MODY) 10/2022 - 06/2018
1	Carcinoma (Carcinomatosis) 10/2022
1	Adenoma (Adenomas) 10/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2022
1	Neoplasms (Cancer) 10/2022
1	Avitaminosis (Vitamin Deficiency) 11/2018
1	Hyperbilirubinemia 11/2014
1	Hemolysis 11/2014
1	Hepatitis C 03/2014
1	Colonic Neoplasms (Colon Cancer) 07/2013

5	Proteins (Proteins, Gene)FDA Link 12/2020 - 05/2012
5	Pharmaceutical PreparationsIBA 12/2020 - 03/2014
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2020 - 05/2012
3	faldaprevirIBA 11/2014 - 03/2014
2	Furosemide (Lasix)FDA LinkGeneric 12/2020 - 09/2015
2	Metformin (Glucophage)FDA LinkGeneric 12/2020 - 09/2015
2	Peptides (Polypeptides)IBA 12/2020 - 09/2015
2	Rosuvastatin Calcium (Crestor)FDA Link 12/2020 - 09/2015
2	Digoxin (Digitek)FDA LinkGeneric 12/2020 - 09/2015
2	Organic Anion TransportersIBA 12/2020 - 09/2015
2	AnionsIBA 12/2020 - 09/2015
1	empagliflozinIBA 10/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022
1	SodiumIBA 10/2022
1	Osmotic DiureticsIBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	Organic Cation Transporter 2IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Bile Acids and Salts (Bile Acids)IBA 11/2018
1	Oxidoreductases (Dehydrogenase)IBA 06/2018
1	CationsIBA 09/2015
1	BilirubinIBA 11/2014
1	Cytochrome P-450 CYP3AIBA 03/2014
1	Complementary DNA (cDNA)IBA 07/2013
1	Multidrug Resistance-Associated Protein 2IBA 05/2012
1	zosuquidar trihydrochloride (LY335979)IBA 05/2012
1	RacivirIBA 05/2012
1	tryptoquivalineIBA 05/2012